Question
Pathophysiology Question on Neoplastic diseases
Trastuzumab is a/an
A
EGFR/HER 2 inhibitor
B
Angiogenesis inhibitor
C
EGF Receptor HER inhibitor
D
BCR-ABL tyrosine kinase inhibitors
Answer
EGFR/HER 2 inhibitor
Explanation
Solution
The correct option is (A):Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer.